Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)
Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –
Ironwood Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Ironwood Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was 33.4%. For fiscal 2025 it was 8.1%, against 0.3% the year before. The highest annual figure on record is 127.7% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.1% | +7.9 |
| FY2024 | Dec 31, 2024 | 0.3% | +226.6 |
| FY2023 | Dec 31, 2023 | -226.4% | −269.0 |
| FY2022 | Dec 31, 2022 | 42.6% | −85.1 |
| FY2021 | Dec 31, 2021 | 127.7% | +100.5 |
| FY2020 | Dec 31, 2020 | 27.3% | +22.2 |
| FY2019 | Dec 31, 2019 | 5.0% | +86.5 |
| FY2018 | Dec 31, 2018 | -81.5% | −42.3 |
| FY2017 | Dec 31, 2017 | -39.2% | −9.4 |
| FY2016 | Dec 31, 2016 | -29.8% | +65.6 |
| FY2015 | Dec 31, 2015 | -95.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 45.4% | +17.7 |
| Q1 FY2026 | Mar 31, 2026 | 38.3% | +129.2 |
| Q4 FY2025 | Dec 31, 2025 | -4.8% | −7.3 |
| Q3 FY2025 | Sep 30, 2025 | 32.8% | +28.9 |
| Q2 FY2025 | Jun 30, 2025 | 27.7% | +28.6 |
| Q1 FY2025 | Mar 31, 2025 | -90.9% | −85.3 |
| Q4 FY2024 | Dec 31, 2024 | 2.5% | +3.4 |
| Q3 FY2024 | Sep 30, 2024 | 4.0% | −9.5 |
| Q2 FY2024 | Jun 30, 2024 | -0.9% | +988.3 |
| Q1 FY2024 | Mar 31, 2024 | -5.6% | −49.5 |
| Q4 FY2023 | Dec 31, 2023 | -0.9% | −46.5 |
| Q3 FY2023 | Sep 30, 2023 | 13.5% | −32.8 |
| Q2 FY2023 | Jun 30, 2023 | -989.2% | −1027.3 |
| Q1 FY2023 | Mar 31, 2023 | 43.9% | +4.1 |
| Q4 FY2022 | Dec 31, 2022 | 45.6% | +10.3 |
| Q3 FY2022 | Sep 30, 2022 | 46.3% | −7.5 |
| Q2 FY2022 | Jun 30, 2022 | 38.1% | −338.0 |
| Q1 FY2022 | Mar 31, 2022 | 39.8% | −5.2 |
| Q4 FY2021 | Dec 31, 2021 | 35.3% | −1.7 |
| Q3 FY2021 | Sep 30, 2021 | 53.8% | +20.6 |
| Q2 FY2021 | Jun 30, 2021 | 376.1% | +348.0 |
| Q1 FY2021 | Mar 31, 2021 | 44.9% | +40.8 |
| Q4 FY2020 | Dec 31, 2020 | 37.0% | −0.9 |
| Q3 FY2020 | Sep 30, 2020 | 33.3% | +17.5 |
| Q2 FY2020 | Jun 30, 2020 | 28.2% | +16.2 |
| Q1 FY2020 | Mar 31, 2020 | 4.2% | +90.4 |
| Q4 FY2019 | Dec 31, 2019 | 37.9% | +49.7 |
| Q3 FY2019 | Sep 30, 2019 | 15.7% | +281.2 |
| Q2 FY2019 | Jun 30, 2019 | 12.0% | +72.9 |
| Q1 FY2019 | Mar 31, 2019 | -86.3% | −23.9 |
| Q4 FY2018 | Dec 31, 2018 | -11.9% | −24.7 |
| Q3 FY2018 | Sep 30, 2018 | -265.4% | −228.2 |
| Q2 FY2018 | Jun 30, 2018 | -60.9% | +7.1 |
| Q1 FY2018 | Mar 31, 2018 | -62.4% | +38.3 |
| Q4 FY2017 | Dec 31, 2017 | 12.8% | +28.3 |
| Q3 FY2017 | Sep 30, 2017 | -37.2% | +13.0 |
| Q2 FY2017 | Jun 30, 2017 | -68.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -100.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -15.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -50.2% | – |
See a number that looks wrong?